Axon Rises on Institutional Buys as Execs Sell, Stock Traders 352nd in $300M Volume

On August 22, 2025, Axon Enterprise (AXON) closed with a 0.36% gain, trading at a volume of $300 million, ranking 352nd in market activity. Institutional investor BI Asset Management reduced its stake in Axon by 12.9%, holding 14,400 shares valued at $7.57 million, while Hsbc Holdings increased holdings by 46.9%, acquiring over 83,000 additional shares. Insider transactions revealed significant sales by senior executives, with CRO Cameron Brooks and President Joshua Isner reducing their ownership by 13.36% and 6.26%, respectively, through large share disposals.

Recent analyst activity highlighted growing institutional confidence in Axon, as multiple firms raised price targets and maintained "buy" ratings. Goldman Sachs and JPMorgan elevated their price objectives to $830 and $850, respectively, while Wolfe Research initiated coverage with an "outperform" rating. Despite mixed insider sentiment, Axon’s institutional ownership remains robust at 79.08%, with hedge funds collectively increasing stakes by over 10% in the first quarter. Earnings momentum continued, with Q2 revenue rising 32.6% year-over-year to $668.54 million, exceeding estimates and reflecting strong demand for its software and TASER segments.

The strategy of buying the top 500 stocks by daily trading volume and holding for one day from 2022 to 2025 yielded a 0.98% average daily return, with a total return of 31.52% over 365 days. The approach generated a Sharpe ratio of 0.79, indicating favorable risk-adjusted performance, though it faced a maximum drawdown of -29.16% during market downturns.